• 7.png

Speakers and Topics .Download


The 7th World Congress of Chinese Medicine Oncology Speskers and Topics

 Date:November 16-17,2019(main conference site),18-19(satellite conference site)

Location:Hilton San Francisco Financial District Convention Center(main conference site),       

750 Kearny St.San Francisco,CA 94108

Vitality University(satellite conference site)

2497-2499 Industrial PKWY West,Hayward,CA 94545

      Website: www.universityofherbalmedicine.org


Thanks to the support of the Chinese and Western medical experts, the preparations for the 7th World Congress of Chinese Medicine Oncology were proceeding smoothly. The first batch of speakers and the introduction of the presentations are being issued. With more speakers and presentations being finalized, the second batch will be issued before September 1. The conference  continues to accept the registration of Chinese and Western medical experts and colleagues.


Introduction

Speaker:Dr. Jeffrey Zhongxue Mah ( Ma Zhongxue)

Presentation place: Main and Branch Venues

Dr. Jeffrey Zhongxue Mah ( Ma Zhongxue) , Ph.D., graduated from Beijing University of Chinese Medicine,  received the Master’s degree  from Henan University of Traditional Chinese Medicine, and Doctorate of Medicine  from Qinghai University School of Medicine. He was named one of the 26 academic leaders of the Beijing University System in China in 1992. In 1996, he came to the United States and founded consotherapy - an academic system of evidence-based  Chinese medicine oncology. Engaged in medical practices and teaching for more than 40 years, he has written more than 10 books and published more than 100 papers. He is currently the president and professor of the Vitality University located at San Francisco Bay Area.

 

Topic and Content Summary

Topic 1: Introduction of the Evidence-based Chinese Medicine Oncology and Consotherapy (Main Conference Site)

Evidence-based medicine (abbreviated as EBM) is based on the results of comprehensive analysis of the best evidence available to the individual to maximize the medical care for the patient. How would Chinese medicine achieve the medical purpose of EBM without X-ray, laboratory and other biomedical diagnostic methods? This lecture will provide details about how to conduct evidence-based Chinese medicine oncology, specifically using Consotherapy to improve the diagnosis and treatment for cancer patients.

 

Topic 2: Clinical Practice of the Evidence-based TCM Oncology and Consotherapy (Branch Venue)

This lecture discusses the clinical use of the evidence-based Chinese medicine oncology in consotherapy. The course is divided into two units: the first one discusses eight treatments of consotherapy, including Consomate One therapy, herbal paste therapy, herbal tea therapy, herbal dietary therapy, acupuncture, moxibustion, tuina therapy, and emotional therapy; the second one, discusses the specific application of consotherapy in common cancers such as lung cancer, liver cancer, stomach cancer, colon cancer, breast cancer, ovarian cancer, brain cancer, lymphoma, sarcoma, etc.

 

Speaker: Dr. Zhang Dongji

Presentation place: Main Conference Site 

Introduction

UCSF Scientist in Immunology (2000-2017); Professor in Immunology , Jilin  University , Changchun, China (1991); Postdoctoral fellow in  Microbiology & Immunology,  University of Manitoba, Canada (1992-2000); Lecture Professor, Vitality University.

Topic and Content Summary

Since 2003, the concept of “Green treatment of tumor” in traditional Chinese medicine (TCM) - emphasizing the constitution change  and quality of life in treating cancer patients – has become a prominent theme in cancer therapy . Enhancing anti-tumor immunity of patient is key for cancer therapy. The presentation discusses the new development of the anti-tumor immunity and the contributions from TCM. The main contents of the lecture is as followings:

1. TCM supporting healthy Qi and enhancing immunity:

Immuno-oncology (IO) is an area in oncology research with many discussions, including tumor vaccine, immune mediated monoclonal antibody(anti-pd-L1), CART, oncolytic virus, etc. Chinese medicine has been shown promising beneficial effects in the areas of 1)promoting cellular immunity, including Killer T cells, tumor suppressor related cytokines (TNFa, TGFb), CART; 2) enhancing humoral immunity including antibody production, recombined  antibody, and 3) improving complement activity and levels. The anti-tumor immunity properties of TCM herbs includes regulating Qi,nourishing Yin, promoting fluid production, nourishing Yin and tonifying blood, and Kidney Yang.

2. One of the main goals of biomedicine is to kill and remove tumor cells . such as small molecule tumor targeted suppression and immune-mediated therapy. Minimally invasive surgery, Low dose radiotherapy, and radio-frequency ablation regulate  cyclic nucleotides in tumor cells and promote the transformation of tumor cells to normal cells. Research has shown the tumor cell killing properties of certain Chinese herbs including promoting blood circulation, resolving blood stasis, removing phlegm and dampness,  resolving hard lump, and removing heat and detoxification.

       3. Changing the microenvironment in which tumor cell grow.

Chinese medicine has been shown have properties of anti-tumor angiogenesis and block the stimulation of certain hormones on which some tumor growth relies, such as prostatic cancer and breast cancer.

       4. The animal models of tumor immunotherapy.

In short, the research on TCM treatment of tumor can make full use of theories and concepts of modern medicine to expand the understanding of TCM anti-tumor effect and develop new medical pathway and theories

 

•Speaker: Dr. Zheng Lihua

Presentation place: Main Conference Site

Introduction 

Dr.Lihua Zheng, Director of the National Engineering Laboratory Experimental Center for Drug Gene and Protein Screening in China. She received PhD of Biology from Northeast Normal University, Master of Pharmacy from Jilin University; and Bachelor of Clinical Medicine from Bethune Medical University. She has undertaken more than 20 major national scientific research projects. She has published more than 50 SCI papers in internationally renowned academic journals, obtained 5 national invention patents, and won 6 provincial and ministerial scientific and technological achievements awards. Her current research focuses: 1. Discovery, identification and new drug development of anti-tumor natural drug small molecule compounds; 2. Screening of effective components of anti-tumor compound Chinese medicine and mechanism of action; 3. Genes and protein targets of anti-tumor effects of traditional Chinese medicine chemical components the study.

 

Topic and Content Summary

Topic: Study on anti-tumor effect and mechanism of Consomate One T13

To study the anti-tumor effect and mechanism of Consomate One T13 on nude mouse model bearing human cervical cancer cells. Experimental results showed that the drug could regulate the expression of a series of genes related to tumor genesis and development and significantly inhibit tumor growth

 

Speaker: Dr. Zhang Qinhong

Presentation place: Main Conference Site

Introduction

Visiting scholar at Stanford University, Ph.D. in acupuncture and tuina at Heilongjiang University of Traditional Chinese Medicine; board member of Hong Kong Special Administrative Region Health Care Fund; member of the Evidence-Based Medicine Methodology Group of the Evidence Prevention Committee of the Chinese Preventive Medicine Association.  Deputy editor of Systematic Review, editors of PLOS ONE, Medicine, Alternative Therapies in Health and Medicine, Medical Acupuncture magazine, BMJ Open, Trials, Internal Medicine Journal,  and Acupuncture in Medicine. He participated in the preparation of three English textbooks, including Chinese Medicine (Deputy Editor), Professional English for Medicine (Editor) and Acupuncture (Editor). He hosted and participated in 14 national, provincial, ministerial, bureau, and school level topics. He won the first prize of Heilongjiang Province Medical and Health New Technology Application Award.

 

Topic: Clinical evaluation of acupuncture for side effects of cancer after chemotherapy

 This study conducts a comprehensive systematic search of the clinical research literature on acupuncture treatment of side effects after chemotherapy through a systematic review of evidence-based medicine. Literature was screened based on strict inclusion and exclusion criteria. Methodological evaluation of the quality of the literature was performed using the Cochrane risk of bias tool. The study combines the results of each study after analyzing the heterogeneity of similar studies was analyzed. The results of this study  provide objective evidence-based medical evidence for the clinical efficacy of acupuncture in the management of side effects after chemotherapy.


Speaker:  Dr. William Dawson

Lecture place: Main Venue

Introduction

For over a decade Dr William Dawson has been a friend and follower of Dr. Mah Zhongxue who have many stories of their adventures together to tell. Dr Dawson is the owner and Chief Resident of Hopewell Medical Acupuncture - Cheng Knowledge Center which is the North American CAM International Headquarters which is recognized by the WHO World Health Organization. Located in Sunnyvale California for the past 11 years this facility is known for highly advanced acupuncture treatments and herbal formulations, computerized diagnostics and proprietary treatment regimens. A graduate from Five Branches University and The University of East West Medicine and a California LAc., Dr. Dawson is a Diplomat in Oriental Medicine Certified by NCCAOM. In 2015 Dr. Dawson was invited by Dr. Cheng Kai, the grandson of the Immortal Dr Cheng Xin Nong, to be the 5th generation inheritor of the family's knowledge of Acupuncture. Since then, each year, Dr. Dawson seeks to host LAcs from around the world at a rare August training event in Beijing China where they learn from both class and hospital rounds settings Cheng Family Acupuncture Secrets. Dr. Dawson is also privileged to be a professor at Dr. Mah's prestigious University of Herbal Medicine in the East Bay, California as well as a guest lecturer at Dr. Mah's Alma Mater, The Beijing University of Chinese Medicine in Beijing China. He is a lecturer at AACMA events and has appeared as a CCTV guest on Beijing National television. 

Topic and Content Summary

Topic: Reversing Dementia with Chinese Medicine and Some Experience on Cancer Cases

The presentation begins by defining the broad spectrum of Dementia from a western medical perspective as well as risk profile and epidemiology.  Clinical tests will be presented  to assist the practitioner to determine the disorder severity and establish a benchmark for measuring progress. Next, Case Studies will be used to illustrate treatment methods of different presentations of Dementia including treatment overviews, results and an overview of current work being done in this area around the world. Finally, Examples of my clinical experiences in helping cancer patients will be introduced.

 

Speaker:  Dr. Zhang Lixin 

Presentation place: Main Conference Site

Introduction

Dr. Zhang is a professor and vice president of Vitality University and a researcher in TCM, health services research, policy and administration and unique background in integrative medicine. She graduated from Beijing University of Chinese Medicine, practiced integrated medicine employing both TCM and biomedicine in China. She received her M.S. in Health Policy and Administration from the University of Illinois at Urbana-Champaign and Ph.D. in Health Services Research, Administration and Policy from the University of Minnesota. She served as faculty at New York College of TCM and lecturer at San Francisco State University. Dr. Zhang is the lead author of the book chapter Traditional medical practices of Asian Americans and the influence of traditional medicine in the United States in Praeger Handbook of Asian American Health: Taking Notice and Taking Action.

 

Topic and Content Summary

Topic:The Prospect and Development Capacity of Chinese Medicine – A Perspective from Cancer Incidence and Mortality World Wide

Cancer remains one of the leading causes of morbidity and mortality worldwide. It was estimated about 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Because of the demographic change and aging of the population, as well as an increasing prevalence of life style risk factors such as smoking, overweight, physical inactivity, and changing reproductive patterns related to  economic development, the morbidity and mortality of cancer is predicted to be increased in the next few decades. It is projected that by 2030 an estimated 21.4 million new cases of cancer and 13.2 million cancer deaths will occur annually around the world, which brings an enormous burden on society. The presentation discusses the incidence and cancer caused mortalities world-wide with the role and prospective of Chinese medicine as adjunct therapy as well as cancer treatment modalities based on clinical trials and research studies of single herbs and herbal formula prescriptions.  

 

Speaker:  Dr. Yougeng Wang

Lecture place: Main and Branch Venues

Introduction

She graduated from Beijing University of Chinese Medicine in 1982. After graduation, she was engaged in clinical and postgraduate teaching at Xiyuan Hospital of China Academy of Chinese Medical Sciences. After many years of study with Professor Xu Jianzhong, a master of Chinese medicine, he participated in the research of "Guben Pill" Chinese patent medicine, which won the first prize of scientific and technological achievements of the Ministry of Health of China. She has been invited to give lectures in Hungary, Singapore, Malaysia and the United States, and has been widely reported by local TV stations, newspapers and magazines. She has unique clinical experience in acupuncture and Chinese medicine treatment for cardiovascular and cerebrovascular diseases and gynecological diseases. During her tenure as a professor at University of Herbal Medicine, she lectured on TCM clinical medicine courses and clinical teaching and was widely welcome by students.

 

Topic and Content Summary

Topic 1:Clinical Experience of TCM Therapy of Common Ovarian Lesions and Ovarian Tumors ( Main Conference Site)

The ovary is a unique structure of women and a factory for the production of female hormones. It is closely related to fertility and health. However, modern women's living habits and work stress can affect ovarian health. Women's common ovarian diseases include early-onset ovarian insufficiency, intrauterine Membranous ectopic tumors, ovarian tumors, etc. This presentation explains the understanding and diagnosis of ovarian function by Chinese and Western medicine, and provides applied clinical experience in acupuncture and Chinese medicine therapy.

 

Topic 2: Introduction to Clinical Experience in TCM Syndrome Differentiation and Treatment of Cardiovascular and Cerebrovascular Diseases ( Satellite Site)

Cardiovascular disease (CVD) refers to diseases of the heart or blood vessels, also known as circulatory diseases and diseases of the circulatory system. Common cardiovascular diseases include coronary syndrome, stroke, hypertensive heart disease, rheumatic heart disease, aneurysm, cardiomyopathy, atrial fibrillation, congenital heart disease, endocarditis, and peripheral arterial obstructive diseases. . This presentation explains the understanding and diagnosis of cardiovascular and cerebrovascular diseases by Chinese and Western medicine, and provides clinical experience in acupuncture and Chinese medicine therapy.

 

Speaker:  Dr. Jin Guang

Presentation place: Main Conference Site

Introduction

Doctor of Medicine, Kyoto University, Japan; Postdoctoral Fellow, Cancer Center, University of Pittsburgh, USA; MD, Norman Bethune University of Medical Sciences. He was resident in the Department of Pathology, Allegheny General Hospital, Pittsburgh, USA. Now he works in California Associated Pathology Medical Group.  He also teaches Western medicine courses at Vitality University.

 

Topic and Content Summary

In modern medical field, the pathology analysis has deeply involved in the cancer diagnosis and treatment process, and already integrated in the cancer management seamlessly. I will briefly introduce the influences of surgical pathology on cancer patient management in the United States.  


Speaker:  Dr. Liang Xunchang

Lecture place: Main Venue

Introduction

Professor of Tongji Medical School, Huazhong University of Science and Technology, Doctor of Medicine, Master's Tutor, with more than 10 master's degree students, and 3 doctoral students. He graduated from the Department of Biophysics and Life Sciences of Wuhan University, and has been engaged in acupuncture analgesia, neurobiology and integrated Chinese and Western medicine for more than 40 years. He has won 3 national and ministerial-level achievements, more than 60 papers published in medical journals at home and abroad, and monographs of five million Chinese words. The main work in the past ten years is mainly clinical, using traditional Chinese medicine acupuncture and Chinese medicine to treat chronic cardiovascular and cerebrovascular diseases in middle-aged and elderly people; various kinds of neuralgia, bone and joint pain, etc., and have done a lot of work in cancer prevention and control, and achieved certain effective results.

Topic and Content Summary

 

Topic: Observation of Taxus Chinensis with acupuncture on Malignant Cancer Patients with Prolonged Life Cycle.

In 1971, American scientists extracted paclitaxel from yew. It has been clinically proven that paclitaxel is effective against various cancers, especially for the treatment of prostate cancer, ovarian cancer, breast cancer and lung cancer. This lecture discusses the anti-cancer efficacy of the original plant of Taxus chinensis as a traditional Chinese medicine. It is combined with acupuncture and moxibustion to observe the curative effect of patients with prolonged life-cycle malignant tumors, and the clinical thinking of anti-cancer in Chinese medicine.

 

Speaker:  Dr. Lou Wei

Lecture place: Branch Venue

Introduction

Topic and Content Summary

Topic: Clinical Experience on Simple Tuina with Acupuncture for Pain Management

In this lecture, I will share with you the theory and practical operation of acupuncture and specific Tuina for pain syndrome. The contents include (1) Basic theory of acupuncture and Tuina for treating pain syndrome, the understanding and differential diagnosis of osteoarthrosis by Chinese and Western medicine, treatment principles and precautions; 2. Clinical experience of acupuncture and Tuina for common pain, and treatment of pain by fire needle and its skill; 3) Use of special munipulation, functional exercise and application: 4) the preparation and application of external Chinese herbal medicine.